Keyword: Tufts Center for Drug Development
No single-source platform for site identification and the lack of a centralized ethics review pathway were cited as slowing the process down.
A recent study by the Tufts Center for the Study of Drug Development found that EDC systems still aren't efficiently accelerating clinical trials.
The new FDA commissioner wants to target drug development costs as yet another study asks how much it really costs to make a medicine.
ContextMedia, a company focused on providing health and drug information, launched a digital platform used in physicians’ offices for clinical trial participants recruitment.